ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-13S8549
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global T Cell NK Cell Engaging Bispecific Antibodies Market Insights Forecast to 2028
BUY CHAPTERS

Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Research Report 2025

Code: QYRE-Auto-13S8549
Report
March 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Immunocore Ltd
Roche
Pfizer Inc
MacroGenics Inc
Amgen Inc
Johnson & Johnson
Regeneron

T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size

The global market for T-Cell & NK-Cell Engaging Bispecific Antibodies was valued at US$ 890 million in the year 2024 and is projected to reach a revised size of US$ 9573 million by 2031, growing at a CAGR of 41.0% during the forecast period.

T-Cell & NK-Cell Engaging Bispecific Antibodies Market

T-Cell & NK-Cell Engaging Bispecific Antibodies Market

A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
Most cell-bridging bsAbs are designed for cancer treatment by linking immune cells to malignant cells. Through sequential binding, that is, by binding the cancer cell first owing to a higher affinity to tumor antigens, cell-bridging bsAbs can improve specificity and effectiveness with reduced non-specific side effects and lower dosage compared with mAbs.
bsAbs are designed to achieve different functions through single or multiple MoAs: bridging tumor cells and immune cells for redirected cytotoxicity, blocking two targets to inhibit tumor growth, promoting immune cell functions, or facilitating the formation of protein complexes.
In this report, we study the Bispecific Antibodies drugs based on T-Cell or NK-Cell.
Drivers of the T-Cell & NK-Cell Engaging Bispecific Antibodies Market
The T-Cell & NK-Cell Engaging Bispecific Antibodies market is driven by the growing prevalence of cancer and the rising demand for advanced immunotherapies. These innovative therapies harness the body’s immune system to target and destroy cancer cells with high precision, offering significant advantages over traditional treatments. Advancements in antibody engineering and the increasing adoption of combination therapies further fuel market growth. Additionally, substantial investments in research and development by pharmaceutical companies and supportive regulatory environments accelerate the development and commercialization of these promising therapeutics.
Challenges in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market
Despite their potential, the market faces challenges such as high development costs and complex manufacturing processes. Producing bispecific antibodies involves intricate design and quality control measures, which can limit scalability and increase expenses. Moreover, the safety profile of these therapies, particularly in managing immune-related adverse events, remains a concern. Regulatory hurdles and the need for extensive clinical trials to demonstrate efficacy and safety also delay product approvals, posing a significant barrier to market entry for smaller companies and new players.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for T-Cell & NK-Cell Engaging Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell & NK-Cell Engaging Bispecific Antibodies.
The T-Cell & NK-Cell Engaging Bispecific Antibodies market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global T-Cell & NK-Cell Engaging Bispecific Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of T-Cell & NK-Cell Engaging Bispecific Antibodies Market Report

Report Metric Details
Report Name T-Cell & NK-Cell Engaging Bispecific Antibodies Market
Accounted market size in year US$ 890 million
Forecasted market size in 2031 US$ 9573 million
CAGR 41.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • T-Cell Engagers
  • NK-Cell Engagers
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Immunocore, Johnson & Johnson, Roche, Pfizer, AbbVie, MacroGenics, Regeneron
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of T-Cell & NK-Cell Engaging Bispecific Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is T-Cell & NK-Cell Engaging Bispecific Antibodies Market growing?

Ans: The T-Cell & NK-Cell Engaging Bispecific Antibodies Market witnessing a CAGR of 41.0% during the forecast period 2025-2031.

What is the T-Cell & NK-Cell Engaging Bispecific Antibodies Market size in 2031?

Ans: The T-Cell & NK-Cell Engaging Bispecific Antibodies Market size in 2031 will be US$ 9573 million.

What is the T-Cell & NK-Cell Engaging Bispecific Antibodies Market share by type?

Ans: In terms of product, T-Cell engagers is the largest segment, with a share over 93%.

What is the T-Cell & NK-Cell Engaging Bispecific Antibodies Market share by application?

Ans: And in terms of application, the largest application is solid tumors, with a share over 71%.

Who are the main players in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market report?

Ans: The main players in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market are Amgen, Immunocore, Johnson & Johnson, Roche, Pfizer, AbbVie, MacroGenics, Regeneron

What are the Application segmentation covered in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market report?

Ans: The Applications covered in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market report are Hematological Cancers, Solid Tumors

What are the Type segmentation covered in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market report?

Ans: The Types covered in the T-Cell & NK-Cell Engaging Bispecific Antibodies Market report are T-Cell Engagers, NK-Cell Engagers

Recommended Reports

Bispecific Antibody Markets

Cell Therapy Innovations

Cancer Drug Therapeutics

1 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Overview
1.1 Product Definition
1.2 T-Cell & NK-Cell Engaging Bispecific Antibodies by Type
1.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value Comparison by Type (2024 VS 2031)
1.2.2 T-Cell Engagers
1.2.3 NK-Cell Engagers
1.3 T-Cell & NK-Cell Engaging Bispecific Antibodies by Application
1.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Application (2024 VS 2031)
1.3.2 Hematological Cancers
1.3.3 Solid Tumors
1.4 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size Estimates and Forecasts
1.4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue 2020-2031
1.4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales 2020-2031
1.4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competition by Manufacturers
2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Manufacturers (2020-2025)
2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Manufacturers (2020-2025)
2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Product Type & Application
2.7 Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Date of Enter into This Industry
2.8 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competitive Situation and Trends
2.8.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Concentration Rate
2.8.2 The Global 5 and 10 Largest T-Cell & NK-Cell Engaging Bispecific Antibodies Players Market Share by Revenue
2.8.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Scenario by Region
3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2020-2031
3.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2020-2025
3.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region: 2026-2031
3.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2020-2031
3.3.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2020-2025
3.3.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2026-2031
3.4 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.4.1 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2031)
3.4.3 North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.5.1 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2031)
3.5.3 Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Region
3.6.1 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2020-2031)
3.6.3 Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.7.1 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2031)
3.7.3 Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Facts & Figures by Country
3.8.1 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2031)
3.8.3 Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2020-2031)
4.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2020-2025)
4.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Type (2026-2031)
4.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2020-2031)
4.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2020-2031)
4.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2020-2025)
4.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Type (2026-2031)
4.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2020-2031)
4.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Type (2020-2031)
5 Segment by Application
5.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2020-2031)
5.1.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2020-2025)
5.1.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Application (2026-2031)
5.1.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2020-2031)
5.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2020-2031)
5.2.1 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2020-2025)
5.2.2 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Application (2026-2031)
5.2.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2020-2031)
5.3 Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Immunocore
6.2.1 Immunocore Company Information
6.2.2 Immunocore Description and Business Overview
6.2.3 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.2.5 Immunocore Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 AbbVie
6.6.1 AbbVie Company Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.6.5 AbbVie Recent Developments/Updates
6.7 MacroGenics
6.7.1 MacroGenics Company Information
6.7.2 MacroGenics Description and Business Overview
6.7.3 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.7.5 MacroGenics Recent Developments/Updates
6.8 Regeneron
6.8.1 Regeneron Company Information
6.8.2 Regeneron Description and Business Overview
6.8.3 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product Portfolio
6.8.5 Regeneron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Chain Analysis
7.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Production Mode & Process Analysis
7.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales and Marketing
7.4.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Channels
7.4.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors
7.5 T-Cell & NK-Cell Engaging Bispecific Antibodies Customer Analysis
8 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Dynamics
8.1 T-Cell & NK-Cell Engaging Bispecific Antibodies Industry Trends
8.2 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
8.3 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
8.4 T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Immunocore Ltd
Roche
Pfizer Inc
MacroGenics Inc
Amgen Inc
Johnson & Johnson
Regeneron
List of Tables
 Table 1. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Competitive Situation by Manufacturers in 2024
 Table 4. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of T-Cell & NK-Cell Engaging Bispecific Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Product Type & Application
 Table 12. Global Key Manufacturers of T-Cell & NK-Cell Engaging Bispecific Antibodies, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global T-Cell & NK-Cell Engaging Bispecific Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2020-2025) & (K Units)
 Table 18. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2020-2025)
 Table 19. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2026-2031) & (K Units)
 Table 20. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2026-2031)
 Table 21. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2020-2025)
 Table 23. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2026-2031)
 Table 25. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2025) & (K Units)
 Table 27. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2026-2031) & (K Units)
 Table 28. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2025) & (K Units)
 Table 32. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2026-2031) & (K Units)
 Table 33. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2020-2025)
 Table 51. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Type (2026-2031)
 Table 52. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2020-2025)
 Table 53. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Type (2026-2031)
 Table 54. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2020-2025)
 Table 57. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Type (2026-2031)
 Table 58. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Type (2020-2025)
 Table 59. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Type (2026-2031)
 Table 60. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Application (2020-2025)
 Table 61. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units) by Application (2026-2031)
 Table 62. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2020-2025)
 Table 63. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Application (2026-2031)
 Table 64. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2020-2025)
 Table 67. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Application (2026-2031)
 Table 68. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Application (2020-2025)
 Table 69. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Application (2026-2031)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Immunocore Company Information
 Table 76. Immunocore Description and Business Overview
 Table 77. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Immunocore T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 79. Immunocore Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Roche T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. AbbVie Company Information
 Table 96. AbbVie Description and Business Overview
 Table 97. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. AbbVie T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 99. AbbVie Recent Developments/Updates
 Table 100. MacroGenics Company Information
 Table 101. MacroGenics Description and Business Overview
 Table 102. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. MacroGenics T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 104. MacroGenics Recent Developments/Updates
 Table 105. Regeneron Company Information
 Table 106. Regeneron Description and Business Overview
 Table 107. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Regeneron T-Cell & NK-Cell Engaging Bispecific Antibodies Product
 Table 109. Regeneron Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. T-Cell & NK-Cell Engaging Bispecific Antibodies Distributors List
 Table 113. T-Cell & NK-Cell Engaging Bispecific Antibodies Customers List
 Table 114. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Trends
 Table 115. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Drivers
 Table 116. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Challenges
 Table 117. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of T-Cell & NK-Cell Engaging Bispecific Antibodies
 Figure 2. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Type: 2024 & 2031
 Figure 4. T-Cell Engagers Product Picture
 Figure 5. NK-Cell Engagers Product Picture
 Figure 6. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Application: 2024 & 2031
 Figure 8. Hematological Cancers
 Figure 9. Solid Tumors
 Figure 10. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size (2020-2031) & (US$ Million)
 Figure 12. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Sales (2020-2031) & (K Units)
 Figure 13. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Average Price (US$/Unit) & (2020-2031)
 Figure 14. T-Cell & NK-Cell Engaging Bispecific Antibodies Report Years Considered
 Figure 15. T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Share by Manufacturers in 2024
 Figure 16. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest T-Cell & NK-Cell Engaging Bispecific Antibodies Players: Market Share by Revenue in T-Cell & NK-Cell Engaging Bispecific Antibodies in 2024
 Figure 18. T-Cell & NK-Cell Engaging Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2020-2031)
 Figure 21. North America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2020-2031)
 Figure 22. United States T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2020-2031)
 Figure 25. Europe T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2020-2031)
 Figure 26. Germany T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Region (2020-2031)
 Figure 33. China T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2020-2031)
 Figure 43. Latin America T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE T-Cell & NK-Cell Engaging Bispecific Antibodies Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Type (2020-2031)
 Figure 53. Global Revenue Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Type (2020-2031)
 Figure 54. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Application (2020-2031)
 Figure 56. Global Revenue Market Share of T-Cell & NK-Cell Engaging Bispecific Antibodies by Application (2020-2031)
 Figure 57. Global T-Cell & NK-Cell Engaging Bispecific Antibodies Price (US$/Unit) by Application (2020-2031)
 Figure 58. T-Cell & NK-Cell Engaging Bispecific Antibodies Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Bi Specific MAbS Market Research Report 2024
Global Bispecific Antibody Technology Platform Market Research Report 2025
Bispecific Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Antibodies Drug Market Research Report 2025
Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030
Global Bispecific Antibody Development Platform Market Research Report 2024
Global Bispecific Antibody Molecular Drug Market Research Report 2025
Global Cell bridging Bispecific Antibodies Market Research Report 2025
Bispecific and Trispecific Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Humanized Bispecific Antibody Market Research Report 2024
Global Humanized Bispecific Antibodies Market Research Report 2024
Global T cell Bispecific Antibodies Drug Market Research Report 2025
Global CD Targeted Bispecific Antibody Market Research Report 2024
Global Tumor Therapy Bispecific T Cell Adaptor Market Research Report 2025
Global Bispecific Antibody Therapeutic Market Insights Forecast to 2030
Global BCMA CD3 Bispecific Antibody Market Research Report 2024
BiSpecific MAbS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Bispecific Monoclonal Antibodies Market Research Report 2024
Bispecific Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bi Specific Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions